Beta Bionics, Inc. (BBNX) Earnings History
Annual and quarterly earnings data from 2022 to 2025
Loading earnings history...
BBNX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
BBNX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 55.4% | -71.5% | -73.0% |
| 2024 | 55.1% | -69.5% | -84.1% |
| 2023 | 52.6% | -298.9% | -367.6% |
| 2022 | 100.0% | -36784.4% | -36173.7% |
Download Data
Export BBNX earnings history in CSV or JSON format
Free sign-in required to download data
Beta Bionics, Inc. (BBNX) Earnings Overview
As of May 8, 2026, Beta Bionics, Inc. (BBNX) reported trailing twelve-month net income of -$66M, reflecting +79.0% year-over-year growth. The company earned $-1.50 per diluted share over the past four quarters, with a net profit margin of -73.0%.
Looking at the long-term picture, BBNX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$44M in fiscal 2023.
Beta Bionics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including TNDM (-$95M net income, -20.2% margin), PODD ($303M net income, 9.1% margin), DXCM ($930M net income, 17.9% margin), BBNX has room to improve margins relative to the peer group. Compare BBNX vs TNDM →
BBNX Earnings vs Peers
Earnings metrics vs comparable public companies
BBNX Historical Earnings Data (2022–2025)
4 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$73M | -33.7% | -$72M | $-1.81 | -73.0% | -71.5% |
| 2024 | -$55M | -24.2% | -$45M | $-8.60 | -84.1% | -69.5% |
| 2023 | -$44M | +31.9% | -$36M | $-8.31 | -367.6% | -298.9% |
| 2022 | -$65M | - | -$66M | $-12.96 | -36173.7% | -36784.4% |
See BBNX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BBNX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BBNX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBBNX — Frequently Asked Questions
Quick answers to the most common questions about buying BBNX stock.
Is BBNX growing earnings?
BBNX EPS is $-1.50, with earnings growth accelerating to +79.0%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-66M.
What are BBNX's profit margins?
Beta Bionics, Inc. net margin is -73.0%, with operating margin at -71.5%. Below-average margins reflect competitive or cost pressures.
How consistent are BBNX's earnings?
BBNX earnings data spans 2022-2025. The accelerating earnings trend is +79.0% YoY. Historical data enables comparison across business cycles.